том 60 издание 11 страницы 1780-1785

Clinical evaluation of the OC-Sensor Pledia calprotectin assay

Тип публикацииJournal Article
Дата публикации2022-09-12
scimago Q1
wos Q1
white level БС1
SJR0.952
CiteScore6.9
Impact factor3.7
ISSN14346621, 14374331
General Medicine
Clinical Biochemistry
Biochemistry (medical)
Краткое описание
Objectives

Faecal calprotectin (f-Cal) and faecal haemoglobin (f-Hb) are important tests for evaluation of gastrointestinal disease. Samples for measurement of f-Hb are taken by the patient directly into a specimen collection device containing stabilising buffer, which can be placed directly onto the analyser in the laboratory. Samples for f-Cal are usually sent in screw top pots and often require time-consuming extraction procedures prior to analysis. OC-FCa calprotectin is a new assay which uses the same specimen collection device and analyser as our current f-Hb assay. Analytical evaluation has already shown it to perform well but to have a positive bias. This study was a clinical evaluation to investigate the diagnostic test performance and cut-off suitable for its use in the diagnosis of IBD.

Methods

OC-FCa calprotectin was measured in a convenience sample of 603 patients in whom f-Hb had been requested and was found to be ≥10 μg/g. Clinical outcomes were obtained from notes, radiological reports and endoscopy and histology reports.

Results

A total of 425 patients completed clinical investigations; IBD was diagnosed in 49 and other colorectal pathology in 161. Median f-Cal in patients with IBD was 1,660 μg/g, significantly different (p<0.01) from those with other colorectal pathology (192 μg/g) or normal findings (157 μg/g). ROC curve analysis showed AUC of 0.898 with sensitivity of 91.8% and specificity of 79.3% at a cut-off of 600 μg/g.

Conclusions

The new OC-FCa calprotectin assay performed well for the diagnosis of IBD using a cut-off of 600 μg/g.

Для доступа к списку цитирований публикации необходимо авторизоваться.

Топ-30

Журналы

1
Frontline Gastroenterology
1 публикация, 33.33%
Annals of Clinical Biochemistry
1 публикация, 33.33%
Diagnostics
1 публикация, 33.33%
1

Издатели

1
BMJ
1 публикация, 33.33%
SAGE
1 публикация, 33.33%
MDPI
1 публикация, 33.33%
1
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
3
Поделиться
Цитировать
ГОСТ |
Цитировать
Butenas J., Ayling R. M. Clinical evaluation of the OC-Sensor Pledia calprotectin assay // Clinical Chemistry and Laboratory Medicine. 2022. Vol. 60. No. 11. pp. 1780-1785.
ГОСТ со всеми авторами (до 50) Скопировать
Butenas J., Ayling R. M. Clinical evaluation of the OC-Sensor Pledia calprotectin assay // Clinical Chemistry and Laboratory Medicine. 2022. Vol. 60. No. 11. pp. 1780-1785.
RIS |
Цитировать
TY - JOUR
DO - 10.1515/cclm-2022-0526
UR - https://doi.org/10.1515/cclm-2022-0526
TI - Clinical evaluation of the OC-Sensor Pledia calprotectin assay
T2 - Clinical Chemistry and Laboratory Medicine
AU - Butenas, Juozas
AU - Ayling, Ruth M.
PY - 2022
DA - 2022/09/12
PB - De Gruyter Brill
SP - 1780-1785
IS - 11
VL - 60
PMID - 36087065
SN - 1434-6621
SN - 1437-4331
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2022_Butenas,
author = {Juozas Butenas and Ruth M. Ayling},
title = {Clinical evaluation of the OC-Sensor Pledia calprotectin assay},
journal = {Clinical Chemistry and Laboratory Medicine},
year = {2022},
volume = {60},
publisher = {De Gruyter Brill},
month = {sep},
url = {https://doi.org/10.1515/cclm-2022-0526},
number = {11},
pages = {1780--1785},
doi = {10.1515/cclm-2022-0526}
}
MLA
Цитировать
Butenas, Juozas, et al. “Clinical evaluation of the OC-Sensor Pledia calprotectin assay.” Clinical Chemistry and Laboratory Medicine, vol. 60, no. 11, Sep. 2022, pp. 1780-1785. https://doi.org/10.1515/cclm-2022-0526.
Ошибка в публикации?